Journal Article |
| Shostakovich-Koretskaya L, Catano G, Chykarenko ZA, He W, Gornalusse G, Mummidi S, Sanchez R, Dolan MJ, Ahuja SS, Clark RA, Kulkarni H, Ahuja SK. Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children AIDS 2009 Mar;23(6):679-688.
|
| Camargo JF, Quinones MP, Mummidi S, Srinivas S, Gaitan AA, Begum K, Jimenez F, VanCompernolle S, Unutmaz D, Ahuja SS, Ahuja SK. CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation J Immunol 2009 Jan;182(1):171-182.
|
| Gornalusse G, Mummidi S, He W, Silvestri G, Bamshad M, Ahuja SK. CCL3L Copy number variation and the co-evolution of primate and viral genomes PLoS Genet 2009 Jan;5(1):1000359-1000359.
|
| Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, Anderson S, Delmar J, Telles V, Song L, Castiblanco J, Clark RA, Dolan MJ, Ahuja SK, Delmar JA. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles PLoS ONE 2008 Nov;3(11):3636-3636.
|
| Mummidi S, Bonello GB, Ahuja SK. Confirmation of differential binding of Interferon Regulatory Factor-1 (IRF-1) to the functional and HIV disease-influencing -2578 A/G polymorphism in CCL2 Genes Immun 2008 Oct;.
|
| Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM, Ahuja SK. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus Ann Rheum Dis 2008 Aug;67(8):1076-1083.
|
| He W, Neil S, Kulkarni H, Wright E, Agan BK, Marconi VC, Dolan MJ, Weiss RA, Ahuja SK. Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility Cell Host Microbe 2008 Jul;4(1):52-62.
|
| Catano G, Agan BK, Kulkarni H, Telles V, Marconi VC, Dolan MJ, Ahuja SK. Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations J Infect Dis 2008 Jul;198(1):72-80.
|
| Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression Proc Natl Acad Sci U S A 2008 Jun;105(25):8718-8723.
|
| Moore JP, Klasse PJ, Dolan MJ, Ahuja SK. AIDS/HIV. A STEP into darkness or light? Science 2008 May;320(5877):753-755.
|
| Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, OConnell RJ, Marconi VC, Delmar J, Eron J, Clark RA, Frost S, Martin J, Ahuja SS, Deeks SG, Little S, Richman D, Hecht FM, Dolan MJ, Kulkarni HR. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals Nat Med 2008 Apr;14(4):413-420.
|
| Quinones MP, Kalkonde Y, Estrada CA, Jimenez F, Ramirez R, Mahimainathan L, Mummidi S, Choudhury GG, Martinez H, Adams L, Mack M, Reddick RL, Maffi S, Haralambous S, Probert L, Ahuja SK, Ahuja SS. Role of astrocytes and chemokine systems in acute TNFalpha induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-kappaB and Akt Mol Cell Neurosci 2008 Jan;37(1):96-109.
|
| Camargo JF, Quinones MP, Mummidi S, Srinivas S, Begum K, Jimenez F, VanCompernolle S, Unutmaz D, Ahuja SS, Ahuja SK. CCR5 expression levels influence positively NFAT transactivation, IL-2 production and subsequent events during T lymphocyte activation J Immunol. In Press 2008 Jan;.
|
| Dolan MJ**, Kulkarni H**, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R, Clark RA, Anderson SA, Delmar J, OConnell RJ, Lloyd A, Martin J, Ahuja SS, Agan BK, Walker BD, Deeks SG, Ahuja SK (** These authors contributed equally as first authors. This article was accompanied by a commentary: Lederman MM, Sieg SF. CCR5 and its ligands: a new axis of evil? Nat Immunol. 2007;8(12):1283-5.). CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms Nat Immunol 2007 Dec;8(12):1324-1336.
|
| Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM, Ahuja SK. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythematosus Ann Rheum Dis 2007 Nov;.
|
| Mummidi S, Adams LM, Vancompernolle SE, Kalkonde M, Camargo JF, Kulkarni H, Bellinger AS, Bonello G, Tagoh H, Ahuja SS, Unutmaz D, Ahuja SK. Production of Specific mRNA Transcripts, Usage of an Alternate Promoter, and Octamer-Binding Transcription Factors Influence the Surface Expression Levels of the HIV Coreceptor CCR5 on Primary T Cells J Immunol 2007 May;178(9):5668-5681.
|
| Quinones MP, Estrada CA, Jimenez F, Martinez H, Willmon O, Kuziel WA, Ahuja SK, Ahuja SS. CCL2-independent role of CCR2 in immune responses against Leishmania major Parasite Immunol 2007 Apr;29(4):211-217.
|
| Quinones MP, Martinez HG, Jimenez F, Estrada CA, Dudley M, Willmon O, Kulkarni H, Reddick RL, Fernandes G, Kuziel WA, Ahuja SK, Ahuja SS. CC chemokine receptor 5 influences late-stage atherosclerosis Atherosclerosis 2007 Jan;195(1):92-103.
|
| Kalkonde YV, Morgan WW, Sigala J, Maffi SK, Condello C, Kuziel W, Ahuja SS, Ahuja SK. Chemokines in the MPTP model of Parkinsons disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration Brain Res 2007 Jan;1128(1):1-11.
|
| Silverberg MJ, Wegner SA, Milazzo MJ, McKaig RG, Williams CF, Agan BK, Armstrong AW, Gange SJ, Hawkes C, OConnell RJ, Ahuja SK, Dolan MJ. Effectiveness of highly-active antiretroviral therapy by race/ethnicity AIDS 2006 Jul;20(11):1531-1538.
|
| Quinones MP, Jimenez F, Martinez H, Estrada CA, Willmon O, Dudley M, Kuziel WA, Melby PC, Reddick RL, Ahuja SK, Ahuja SS. CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium J Mol Med 2006 Jun;84(6):503-512.
|
| Sundrud MS, Vancompernolle SE, Eger KA, Bruno TC, Subramaniam A, Mummidi S, Ahuja SK, Unutmaz D. Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells Blood 2005 Nov;106(10):3440-3448.
|
| Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease J Infect Dis 2005 Jul;192(2):344-349.
|
| Gonzalez E**, Kulkarni H**, Bolivar H**, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, Oconnell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK (** These authors contributed equally as first authors. This article was accompanied by a commentary: Nolan D, James I, Mallal S. HIV/AIDS. HIV: experiencing the pressures of modern life. Science. 2005;307(5714):1422-4. This work has been cited 254 times in various journals.). The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility Science 2005 Mar;307:1434-1440.
|
| Ahuja SK, Catano G. Sharing is caring, except when it comes to HLA-class-I alleles in HIV-1 transmission Lancet 2004 Jun;363(9427):2103-2104.
|
| Quinones MP, Ahuja SK, Jimenez F, Schaefer J, Garavito E, Rao A, Chenaux G, Reddick RL, Kuziel WA, Ahuja SS. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis J Clin Invest 2004 Mar;113(6):856-866.
|
| Ahuja SK, Ferreira GM, Moreira AR. Application of Plackett-Burman design and response surface methodology to achieve exponential growth for aggregated shipworm bacterium Biotechnol Bioeng 2004 Mar;85(6):666-675.
|
| Ahuja SK, Ferreira GM, Moreira AR. Production of an endoglucanase by the shipworm bacterium, Teredinobacter turnirae J Ind Microbiol Biotechnol 2004 Jan;31(1):41-47.
|
Abstract |
| Quinones MP, Ahuja SK, Reddick RL, Jimenez F, Melby PC, Kuziel WA, Ahuja SS. Role of CCR2 in autoimmune arthritis; 2004 Sep. (Arthritis Rheum; vol. 50, no. 9).
|
| Ahuja SS, Quinones MP, Jimenez F, Martinez H, Perez J, Kuziel WA, Reddick RL, Ahuja SK. Contrasting Effects of CCR2 and CCR5 in Atherosclerosis; 2004 Jul. (ICI/FCOS Montreal Canada).
|
Review Article |
| Quinones MP, Estrada CA, Kalkonde Y, Ahuja SK, Kuziel WA, Mack M, Ahuja SS. The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis J Mol Med 2005 Sep;83(9):672-681.
|
Not Specified |
| Ketas TJ, Kuhmann SE, Palmer A, Zurita J, He W, Ahuja SK, Klasse PJ, Moore JP. Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands Virology 2007 Aug;364(2):281-290.
|
| Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman DD, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA. A plea for justice for jailed medical workers Science 2006 Nov;314(5801):924-925.
|